Kiran Patel, MD on EGFR Exon 20 Insertion-Mutated NSCLC #ASCO2020 @JanssenUS #ASCO

Kiran Patel, MD on EGFR Exon 20 Insertion-Mutated NSCLC #ASCO2020 @JanssenUS #ASCO

Cancer-News

2 weeks
19 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 1
Category:
Description:

Kiran Patel, MD of Janssen @JanssenUS discusses phase 1 results for bispecific antibody amivantamab in thetreatment of patients with advanced non-small cell lung cancer harboring exon 20 insertion mutations.

Read here: https://meetinglibrary.asco.org/record/184802/abstract

Up Next Autoplay